These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247 [TBL] [Abstract][Full Text] [Related]
9. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757 [TBL] [Abstract][Full Text] [Related]
10. Varying nicotine patch dose and type of smoking cessation counseling. Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558 [TBL] [Abstract][Full Text] [Related]
11. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal. Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080 [TBL] [Abstract][Full Text] [Related]
12. Cotinine: effects with and without nicotine. Hatsukami D; Pentel PR; Jensen J; Nelson D; Allen SS; Goldman A; Rafael D Psychopharmacology (Berl); 1998 Jan; 135(2):141-50. PubMed ID: 9497019 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Sachs DP; Säwe U; Leischow SJ Arch Intern Med; 1993 Aug; 153(16):1881-90. PubMed ID: 8110249 [TBL] [Abstract][Full Text] [Related]
14. Nicotine patches and the subjective effects of cigarette smoking: a pilot study. Cárdenas L; Busto UE; MacDonald A; Corrigall WA Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575 [TBL] [Abstract][Full Text] [Related]
15. Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS J Clin Pharmacol; 1998 Jun; 38(6):510-6. PubMed ID: 9650540 [TBL] [Abstract][Full Text] [Related]
16. Cotinine replacement levels for a 21 mg/day transdermal nicotine patch in an outpatient treatment setting. Gariti P; Alterman AI; Barber W; Bedi N; Luck G; Cnaan A Drug Alcohol Depend; 1999 Apr; 54(2):111-6. PubMed ID: 10217550 [TBL] [Abstract][Full Text] [Related]
17. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Benowitz NL; Zevin S; Jacob P Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580 [TBL] [Abstract][Full Text] [Related]
18. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk. Ilett KF; Hale TW; Page-Sharp M; Kristensen JH; Kohan R; Hackett LP Clin Pharmacol Ther; 2003 Dec; 74(6):516-24. PubMed ID: 14663454 [TBL] [Abstract][Full Text] [Related]
19. Effects of cotinine on cigarette self-administration. Hatsukami D; Lexau B; Nelson D; Pentel PR; Sofuoglu M; Goldman A Psychopharmacology (Berl); 1998 Jul; 138(2):184-9. PubMed ID: 9718288 [TBL] [Abstract][Full Text] [Related]
20. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]